Differential diagnosis and management of acute profound thrombocytopenia by tirofiban: A case report


DEMİRKAN B., Guray Y., GÜRAY Ü., Korkmaz S.

Journal of Thrombosis and Thrombolysis, cilt.22, sa.1, ss.77-78, 2006 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 22 Sayı: 1
  • Basım Tarihi: 2006
  • Doi Numarası: 10.1007/s11239-006-7789-1
  • Dergi Adı: Journal of Thrombosis and Thrombolysis
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.77-78
  • Anahtar Kelimeler: tirofiban, thrombocytopenia, GPIIb/IIIa inhibitors
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

Although the glycoprotein IIb/IIIa receptor inhibitors have improved outcomes of patients with acute coronary syndrome (ACS), therapy with these agents may cause thrombocytopenia with bleeding complications. This adverse effect is seemed to be rare with tirofiban. In this report, we describe a case of acute profound thrombocytopenia within two hours of tirofiban administration and review the differential diagnosis and the management of thrombocytopenia. © Springer Science + Business Media, LLC 2006.